✦ LIBER ✦

Antithrombotic Effects of Rosiglitazone-Metformin versus Glimepiride-Metformin Combination Therapy in Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome

✍ Scribed by Dr. Giuseppe Derosa; Dr. Antonio V. Gaddi; Dr. Mario N. Piccinni; Dr. Leonardina Ciccarelli; Dr. Sibilla Salvadeo; Dr. Emmanouil Peros; Ms. Morena Ghelfi; Ms. Ilaria Ferrari; Dr. Arrigo F. G. Cicero

Book ID: 115049141
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 86 KB
Volume: 25
Category: Article
ISSN: 0277-0008
DOI: 10.1592/phco.25.5.637.63587

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of glimepiride/metformin combin

Efficacy of glimepiride/metformin combination versus glibenclamide/metformin in patients with uncontrolled type 2 diabetes mellitus

✍ Manuel González-Ortiz; Jesús F. Guerrero-Romero; Rafael Violante-Ortiz; Niels Wa 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Beyond Metformin: Initiating Combination

Beyond Metformin: Initiating Combination Therapy in Patients with Type 2 Diabetes Mellitus

✍ Jennifer D. Goldman-Levine 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB

Control of metabolic syndrome with metfo

Control of metabolic syndrome with metformin in obese type 2 diabetes mellitus patients

✍ D.A. De Luis; L. Cuellar; C. Terroba; R. Aller; D. Bellido; G. Piedrola; A. Bece 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 204 KB

Metabolic effects of pioglitazone and ro

Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with metformin

✍ G. Derosa; A. D’Angelo; P. D. Ragonesi; L. Ciccarelli; M. N. Piccinni; F. Pricol 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

Initial treatment with rosiglitazone/met

Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes

✍ J. Rosenstock; J. Rood; A. Cobitz; N. Biswas; H. Chou; A. Garber 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 284 KB

Metformin–pioglitazone and metformin–ros

Metformin–pioglitazone and metformin–rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome

✍ G. Derosa; A. D'Angelo; P. D. Ragonesi; L. Ciccarelli; M. N. Piccinni; F. Pricol 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB